20 research outputs found
Additional file 15 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 15: Supplemental Figure 10. Examination of lung metastasis in a subcutaneous transplantation model using Rasa1-KO S1M cells
Additional file 13 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 13: Supplemental Figure 8. NF2 deficiency induces anoikis resistance via YAP activation
Additional file 2 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 2: Supplemental Table 1. Correlation between RASA1 immunoreactivity and clinicopathological parame ters in human GC tissues. P-value, Chi squared test
Additional file 17 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 17: Supplemental Figure 12. Analysis of Wnt inhibitor expression in response to Nf2-KO and YAP/TAZ signaling modulation
Additional file 8 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 8: Supplemental Figure 3. In vivo validation of target genes using the spleno-hepatic metastasis model
Additional file 5 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 5: Supplemental Table 4. Primer sequences for qPCR and RT-qPCR
Additional file 18 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 18: Supplemental Figure 13. Immunofluorescence staining analysis for Bcl-2, Bcl-xL, β-catenin, and Yap1 in control, Rasa1-KO, Nf2-KO, and Rasa1/Nf2-double-KO peritoneal metastatic foci
Additional file 16 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 16: Supplemental Figure 11. Immunohistochemical analysis of NF2 and β-catenin in human GC tissues
Additional file 4 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 4: Supplemental Table 3. Information of drugs and chemicals used in this study
Additional file 1 of Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
Additional file 1: Materials and methods